Find a Tender · Contract

Medicines Optimisation

A public procurement published by NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) via Find a Tender.

Find a TenderContract
£88k
Award value
Tender value
1
Suppliers
1
Awards
1
Notices
Contract
Stage

Overview

CTMUHB wishes to appoint Bluteq to continue delivery of a Medicines Optimisation electronic approval system for high costs drug for the purpose of providing clinical and financial governance ensuring compliance with NICE and AWMSG recommendations.

Key details

Source
Find a Tender
Lifecycle stage
Contract
Status
complete
CPV classification
Currency
GBP
Total award value
£88,000
Tender value
First published
9 Feb 2026
Last updated
9 Feb 2026
View the original notice

Awards

1 award recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
BlueTeq05334133pending£88k

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award,contractMedicines Optimisation

All suppliers

Frameworks & programmes

More from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

FAQs about this procurement

Who is the buyer for "Medicines Optimisation"?

Medicines Optimisation is a UK public-sector procurement published by NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) via Find a Tender.

Has "Medicines Optimisation" been awarded?

Yes — 1 award is recorded, with a reported total value of £88,000. The current lifecycle stage is "Contract".

Which suppliers are involved in "Medicines Optimisation"?

1 supplier is linked: BlueTeq.

What is "Medicines Optimisation" worth?

The reported award value is £88,000.

When was "Medicines Optimisation" published?

It was first published on 9 Feb 2026 and last updated on 9 Feb 2026, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable